The release on Biomet's site states that former CEO Dane Miller, who resigned from his post in March, could also become an investor in the private company. The buyout is expected to be completed by October 31 of next year, upon which Biomet's stock will be de-listed. The company's interim president, Daniel Hann, said in a statement that becoming a private company will put Biomet in a stronger position.